Drugs Made In Amer Acq Ii Stock Price, News & Analysis
Company Description
Drugs Made In Amer Acq Ii (NASDAQ: DMII) is a publicly traded company in the Blank Checks sector. The company has a market capitalization of $652.5M, ranking #3,194 among all listed U.S. companies by market cap.
DMII stock has gained 0.7% over the past year. Shares last traded at $9.95.
This page provides a comprehensive overview of DMII stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Drugs Made In Amer Acq Ii (DMII) stock last traded at $9.95, up 0.00% from the previous close. Over the past 12 months, the stock has gained 0.7%. At a market capitalization of $652.5M, DMII is classified as a small-cap stock with approximately 65.6M shares outstanding.
Latest News
SEC Filings
Drugs Made In Amer Acq Ii has filed 2 recent SEC filings, including 2 Form 8-K. The most recent filing was submitted on March 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DMII SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Drugs Made In Amer Acq Ii (DMII) currently stands at 86.0 thousand shares, down 17.0% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has increased by 92.2%. This relatively low short interest suggests limited bearish sentiment. The 8.8 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Drugs Made In Amer Acq Ii (DMII) currently stands at 8.8 days, up 783% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 783% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 8.8 days.
DMII Company Profile & Sector Positioning
Drugs Made In Amer Acq Ii (DMII) operates in the Blank Checks sector and is listed on the NASDAQ.